TipHub

₹451.65

▼ -4.79 -1.05%

As of 29 Jul 2026 · delayed

NSE Listed · Pharmaceuticals

Fermenta Biotech Ltd. (FERMENTA)

Volume: 73,788Avg Vol 1W: 1,30,878Avg Vol 1M: 4,69,60952W Range:₹248.85₹479.45
NSE BSE www.fermentabiotech.com AI Report
Key Ratios
Checked just now
Market Cap₹1,329 Cr
Current Price₹451.65
Previous Close₹456.44
High / Low (52w)₹479.45 / ₹248.85
Volume73,788
Avg Vol (1W)1,30,878
Avg Vol (1M)4,69,609
Stock P/E67.82
Book Value₹141.64
Dividend Yield80%
ROE17.67%
ROA10.84%
Revenue (TTM)—
Revenue Growth—
Profit Margin13.66%
Total Debt—
Shares Outstanding3 Cr
Face Value₹5
EPS (TTM)₹6.66
P/B3.19
Debt / Equity0.3
50 DMA₹362.84
200 DMA—
Day change-1.05%
Price Chart
₹451.65▲ 41.85% · 1Y
₹459₹28131.4L
2026-04-20
2026-07-29

20-day avg volume: 5.1L shares

Pros
  • Healthy return on equity of 17.7%.
  • Pays a dividend yield of 80.0%.
  • Company is almost debt-free.
  • Revenue grew 399% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 68.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹78 Cr₹95 Cr₹156 Cr₹140 Cr₹136 Cr₹130 Cr₹137 Cr₹122 Cr
EBITDA₹-2 Cr₹16 Cr₹49 Cr₹35 Cr₹31 Cr₹27 Cr₹23 Cr₹20 Cr
Net Profit₹-6 Cr₹11 Cr₹37 Cr₹34 Cr₹22 Cr₹18 Cr₹13 Cr₹19 Cr
EPS————————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹146 Cr₹481 Cr₹122 Cr₹119 Cr₹107 Cr₹114 Cr₹548 Cr₹110 Cr
EBITDA₹47 Cr₹97 Cr₹31 Cr₹26 Cr₹23 Cr₹22 Cr₹101 Cr₹23 Cr
Net Profit₹35 Cr₹77 Cr₹29 Cr₹16 Cr₹15 Cr₹12 Cr₹72 Cr₹22 Cr
EPS—26.35————24.51—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹551 Cr₹614 Cr₹687 Cr₹707 Cr₹637 Cr₹548 Cr₹614 Cr₹648 Cr
Total Liabilities₹301 Cr₹304 Cr₹327 Cr₹335 Cr₹324 Cr₹263 Cr₹256 Cr₹247 Cr
Equity₹251 Cr₹309 Cr₹360 Cr₹371 Cr₹313 Cr₹285 Cr₹359 Cr₹401 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹123 Cr₹48 Cr₹76 Cr₹53 Cr₹113 Cr₹104 Cr₹44 Cr₹109 Cr
Investing₹-97 Cr₹-44 Cr₹-42 Cr₹-26 Cr₹-55 Cr₹-15 Cr₹0 Cr₹-43 Cr
Financing₹12 Cr₹-47 Cr₹-1 Cr₹-22 Cr₹-41 Cr₹-91 Cr₹-51 Cr₹-42 Cr
Free Cash Flow₹123 Cr₹48 Cr₹76 Cr₹53 Cr₹113 Cr₹104 Cr₹44 Cr₹109 Cr
Shareholding
Promoter 64.09% Institutions 0.17% Public 35.75%
Efficiency & Working Capital
ROCE20.2%
Interest Coverage8.6
Dividend Payout—
Debtor Days74 d
Inventory Days96 d
Payable Days60 d
Cash Conversion Cycle110 d
Working Capital Days170 d
Shareholding Details

As of 2026-06-30

Promoter64.1%
FII0.1%
DII0%
Institutions0.2%
Public35.7%
Promoter Pledge0%
No. of Shareholders14,131
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters62.1%62.1%62.1%62.1%62.1%62.1%64.1%64.1%64.1%64.1%64.1%64.1%
FIIs0%0%0%0%0.1%0%0%0%0%0%0%0.1%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public37.9%37.9%37.9%37.9%37.9%37.9%35.9%35.9%35.9%35.9%35.9%35.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders15,72115,15015,17814,58913,22112,92212,93012,84513,76014,13913,66114,131
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Krishna DatlaShareholding of Promoter and Promoter Group36%1.06 Cr
Satish Varma Azad NadimpallyShareholding of Promoter and Promoter Group11.7%34,53,325
Anupama Datla DesaiShareholding of Promoter and Promoter Group8.7%25,61,265
Preeti ThakkarShareholding of Promoter and Promoter Group7.6%22,40,376
Fermenta Biotech Limited Esop TrustNon Promoter - Non Public2.6%7,50,396
Rakesh Kantilal ShahPublic Shareholding1.8%5,18,432
Krishan PremnarayenPublic Shareholding1.4%4,05,000
Board of Directors
NameDesignationYear
Pradeep Manjunath ChandanChairman & Independent Directo2026
Krishna DatlaVice Chairman & Executive Dire2026
Rajeshwari DatlaNon Executive Director2026
Pramod KasatIndependent Non Exe. Director2026
Rajashri Santosh Kumar OjhaIndependent Non Exe. Director2026
Ramanand MundkurIndependent Director2026
Satish VarmaExecutive Director2026
ANUPAMA DATLA DESAIExecutive Director2026
Prashant NagreManaging Director2026
Varadvinayak KhambeteCS / Compliance Officer / Legal Head2026
Segments — Product
SegmentRevenueShare
Chemicals₹444 Cr97.9%
Property₹10 Cr2.1%
Segments — Geography
RegionRevenueShare
India₹213 Cr44.9%
Europe₹132 Cr27.8%
USA₹32 Cr6.8%
Others countries₹98 Cr20.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹5321514
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-05Dividend (3.75/- per share)Final
dividend2026-08-05₹3.75 (75%)Final
dividend2025-08-06₹2.5 (50%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025470015063
2025000000
202500015015
Insider / Designated-Person Trades

8 recent disclosure(s)

Rajeshwari DatlaDisposal · 5,95,818
Krishna DatlaAcquisition · 5,95,818
Prashant NagreDisposal · 11,000
Prashant NagreDisposal · 67,000
Rajeshwari DatlaAcquisition · 84,400
Krishna DatlaAcquisition · 42,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Off Market26/03/2025 · 5,95,818
Company Information
Incorporated1951
ChairmanPradeep Manjunath Chandan
AuditorS R B C & Co LLP
Investor Email[email protected]; [email protected]
🌐 www.fermentabiotech.com ↗

📍 A-1501 DIL Complex Majiwada, Ghodbunder Road Thane One, Thane (West), Maharashtra, 400610

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

FDCFedders Holding Ltd.Federal Bank Ltd.Fedbank Financial Services Ltd.Future Enterprises Ltd.Felix Industries Ltd.FiberwebFidel Softech LimitedFiem Industries LimitedFilatex India Ltd.Filatex Fashions LimitedFinbud Financial Services Ltd.All “F” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search